Yong-Chul Kim Selected Research

Yong-Chul Kim Research Topics

Disease

43	Neoplasms (Cancer) 12/2023 - 09/2005
23	Pain (Aches) 11/2022 - 12/2003
12	Neuralgia (Stump Neuralgia) 11/2022 - 01/2016
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2023 - 01/2018
6	Infections 11/2023 - 06/2007
6	Peripheral Nervous System Diseases (PNS Diseases) 11/2022 - 01/2016
6	Inflammation (Inflammations) 01/2022 - 02/2012
5	Squamous Cell Carcinoma of Head and Neck 10/2022 - 06/2012
5	Fibrosis (Cirrhosis) 06/2022 - 02/2012
4	Breast Neoplasms (Breast Cancer) 07/2020 - 09/2013
4	Leukemia 06/2020 - 10/2006
4	Chronic Pain 08/2018 - 04/2011
3	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2016
3	IGA Glomerulonephritis (IGA Nephropathy) 01/2018 - 01/2013
3	Colorectal Neoplasms (Colorectal Cancer) 04/2017 - 12/2006
3	Myocarditis (Carditis) 09/2016 - 02/2012
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2013 - 10/2006
2	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2023 - 01/2006
2	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2023 - 07/2022
2	Hyperalgesia 03/2022 - 01/2017
2	Postherpetic Neuralgia 01/2022 - 05/2018
2	Colonic Neoplasms (Colon Cancer) 08/2019 - 12/2017
2	Melanoma (Melanoma, Malignant) 10/2018 - 01/2016
2	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 07/2013
2	Mouth Neoplasms (Oral Cancer) 01/2017 - 04/2015
2	Type 2 Diabetes Mellitus (MODY) 01/2017 - 09/2013
2	Proteinuria 01/2017 - 01/2013
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2016 - 11/2015
2	Necrosis 11/2015 - 01/2013
2	Hypotension (Low Blood Pressure) 06/2015 - 01/2013
1	Lung Neoplasms (Lung Cancer) 01/2024
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2023
1	Atopic Dermatitis (Atopic Eczema) 11/2023
1	COVID-19 11/2023
1	Metabolic Diseases (Metabolic Disease) 11/2023

Drug/Important Bio-Agent (IBA)

11	indirubinIBA 03/2019 - 09/2005
10	Proteins (Proteins, Gene)FDA Link 12/2023 - 07/2005
7	pheophorbide aIBA 10/2022 - 09/2011
7	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2022 - 11/2009
7	Photosensitizing Agents (Photosensitizers)IBA 10/2022 - 11/2009
6	Phosphotransferases (Kinase)IBA 12/2023 - 04/2013
5	Peptide Hydrolases (Proteases)FDA Link 11/2023 - 06/2007
5	Pregabalin (Lyrica)FDA Link 03/2022 - 01/2013
5	Purinergic P2X7 ReceptorsIBA 12/2019 - 10/2006
4	Adenosine Triphosphate (ATP)IBA 02/2022 - 10/2006
4	Opioid Analgesics (Opioids)IBA 10/2018 - 08/2015
4	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2017 - 11/2009
3	Analgesics (Analgesic Drugs)IBA 11/2022 - 01/2017
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2022 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 07/2022 - 02/2015
3	Ion Channels (Ion Channel)IBA 03/2022 - 04/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2009
3	Aurora Kinase AIBA 08/2019 - 04/2017
3	Tacrolimus (Prograf)FDA LinkGeneric 01/2018 - 01/2013
3	Therapeutic UsesIBA 01/2017 - 06/2012
2	Protein Glutamine gamma Glutamyltransferase 2IBA 12/2023 - 06/2022
2	imidazoleIBA 12/2023 - 01/2016
2	Antineoplastic Agents (Antineoplastics)IBA 12/2023 - 07/2018
2	IndazolesIBA 12/2023 - 11/2023
2	Immunosuppressive Agents (Immunosuppressants)IBA 11/2023 - 01/2021
2	ArrestinIBA 11/2022 - 10/2019
2	fms-Like Tyrosine Kinase 3IBA 07/2022 - 05/2019
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2017
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2022 - 09/2010
2	Adenosine (Adenocard)FDA LinkGeneric 01/2022 - 09/2010
2	Peptides (Polypeptides)IBA 01/2021 - 04/2015
2	NucleotidesIBA 01/2021 - 07/2005
2	tyrosine receptor (receptor, tyrosine)IBA 06/2020 - 01/2018
2	Lidocaine (Xylocaine)FDA LinkGeneric 08/2019 - 05/2018
2	ProdrugsIBA 07/2018 - 01/2017
2	Saline SolutionIBA 05/2018 - 09/2010
2	LigandsIBA 01/2018 - 03/2014
2	EnzymesIBA 12/2017 - 04/2011
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2016 - 01/2006
2	5-nitro-5'-hydroxyindirubin-3'-oximeIBA 11/2015 - 04/2013
2	Nuclear Antigens (Extractable Nuclear Antigens)IBA 11/2015 - 06/2012
2	Docetaxel (Taxotere)FDA Link 03/2014 - 09/2013
2	Fibronectins (Fibronectin)IBA 03/2014 - 10/2012
2	pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acidIBA 01/2013 - 07/2005
2	Protein Kinases (Protein Kinase)IBA 08/2012 - 01/2009
2	NAD (NADH)IBA 04/2011 - 06/2009
1	benzimidazoleIBA 12/2023
1	Chlorophyll AIBA 11/2023
1	Interleukin-4 (Interleukin 4)IBA 11/2023
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 11/2023
1	dupilumabIBA 11/2023
1	PolyproteinsIBA 11/2023
1	Imiquimod (Aldara)FDA LinkGeneric 11/2023

Therapy/Procedure

20	Therapeutics 01/2024 - 10/2006
8	Photochemotherapy (Photodynamic Therapy) 10/2022 - 11/2009
5	Ligation 11/2022 - 01/2017
4	Intravenous Administration 02/2022 - 06/2012
4	Drug Therapy (Chemotherapy) 01/2017 - 01/2006
3	Oral Administration 12/2023 - 01/2021
2	Epidural Injections 01/2021 - 01/2017
2	Injections 01/2021 - 09/2013
2	Lasers (Laser) 10/2018 - 01/2016
2	Activities of Daily Living (ADL) 06/2018 - 08/2015
2	Conservative Treatment 01/2017 - 04/2016
1	Intraperitoneal Injections 12/2023